TY  - GEN
AU  - Freeman,D J
AU  - Leclerc,I
AU  - Rutter,G A
TI  - Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review)
SN  - 1107-3756
PY  - 2000///0110
KW  - Adult
KW  - Animals
KW  - Antigens, Neoplasm
KW  - Biomarkers, Tumor
KW  - Blood Glucose
KW  - analysis
KW  - Cell Transplantation
KW  - Diabetes Mellitus, Type 2
KW  - genetics
KW  - Gene Expression Regulation
KW  - Genes, Synthetic
KW  - Genetic Therapy
KW  - Genetic Vectors
KW  - Glucagon
KW  - Glucagon-Like Peptide 1
KW  - Glucokinase
KW  - Glucose Transporter Type 2
KW  - Homeodomain Proteins
KW  - Humans
KW  - Hyperinsulinism
KW  - etiology
KW  - Hypoglycemic Agents
KW  - pharmacology
KW  - Insulin
KW  - Insulin Resistance
KW  - Insulin Secretion
KW  - Islets of Langerhans
KW  - drug effects
KW  - Islets of Langerhans Transplantation
KW  - Lectins, C-Type
KW  - Mice
KW  - Middle Aged
KW  - Monosaccharide Transport Proteins
KW  - Muscle Contraction
KW  - Nitric Oxide
KW  - physiology
KW  - Nitric Oxide Synthase
KW  - Nitric Oxide Synthase Type I
KW  - Pancreatitis-Associated Proteins
KW  - Peptide Fragments
KW  - Promoter Regions, Genetic
KW  - Protein Precursors
KW  - Proteins
KW  - Rats
KW  - Trans-Activators
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.3892/ijmm.4.6.585
ER  -